These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8348073

  • 1. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J, Mysliwska J, Baran W, Hellmann A, Mysliwski A.
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [Abstract] [Full Text] [Related]

  • 2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z, Tomson S, Ozes ON, Taylor MW.
    Blood; 1993 Apr 01; 81(7):1699-708. PubMed ID: 8096405
    [Abstract] [Full Text] [Related]

  • 3. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z, Ozes ON, Blatt LM, Taylor MW.
    J Immunother (1991); 1992 Jan 01; 11(1):40-9. PubMed ID: 1734947
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J, Mysliwska J, Dziadziuszko R, Bigda J, Mysliwski A, Hellmann A.
    Leuk Lymphoma; 1993 May 01; 10(1-2):121-5. PubMed ID: 8104069
    [Abstract] [Full Text] [Related]

  • 5. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B, Hokland P, Ellegaard J, Hasselbalch H, Hokland M.
    Leuk Res; 1989 May 01; 13(6):451-6. PubMed ID: 2770329
    [Abstract] [Full Text] [Related]

  • 6. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L, Ambrosetti A, Zambello R, Agostini C, Masciarelli M, Vinante F, Chilosi M, Pizzolo G, Cetto G, Semenzato G.
    Leuk Res; 1987 May 01; 11(9):843-7. PubMed ID: 3499539
    [Abstract] [Full Text] [Related]

  • 7. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM, De Angelis V, Fizzotti M, Schippa M, Cecchini M, Adiuto D, Di Clemente F, Palmisano L, Micozzi E, Zuccaccia M.
    Cancer Immunol Immunother; 1994 May 01; 38(5):323-31. PubMed ID: 7512888
    [Abstract] [Full Text] [Related]

  • 8. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC, Nimmo JC, Hart DN.
    Pathology; 1988 Oct 01; 20(4):361-5. PubMed ID: 2977221
    [Abstract] [Full Text] [Related]

  • 9. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
    Cordingley FT, Hoffbrand AV, Brenner MK.
    Br J Haematol; 1988 Sep 01; 70(1):37-41. PubMed ID: 3140887
    [Abstract] [Full Text] [Related]

  • 10. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N, Aghai E, Merchav S, Kinarty A, Sobel E, Froom P.
    Scand J Immunol; 1990 Aug 01; 32(2):205-9. PubMed ID: 2389114
    [Abstract] [Full Text] [Related]

  • 11. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD, Cawley JC.
    Leukemia; 1987 Apr 01; 1(4):372-6. PubMed ID: 3669763
    [Abstract] [Full Text] [Related]

  • 12. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
    Lahat N, Aghai E, Kotler A, Kinarty A, Sobel E, Gruener N, Froom P.
    Blood; 1988 Apr 01; 71(4):1141-3. PubMed ID: 3258536
    [Abstract] [Full Text] [Related]

  • 13. [Effects of non-immune interferons and interleukin-2 on the activity of natural killer cells in patients with hairy cell leukemia].
    Schippa M, Fizzotti M, Cini L, Senatore M.
    Medicina (Firenze); 1988 Apr 01; 8(2):163-6. PubMed ID: 3265755
    [No Abstract] [Full Text] [Related]

  • 14. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B, Hokland M, Justesen J, Hasselbalch H, Ellegaard J, Hokland P.
    Eur J Haematol; 1989 Jan 01; 42(1):50-9. PubMed ID: 2914594
    [Abstract] [Full Text] [Related]

  • 15. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R, Fierro MT, Lusso P, Bonferroni M, Raspadori D, Buzzi M, Zinzani PL, Resegotti L, Lauria F.
    Leukemia; 1987 Apr 01; 1(4):377-9. PubMed ID: 3499543
    [Abstract] [Full Text] [Related]

  • 16. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ, Vardiman JW, Golomb HM.
    Semin Oncol; 1986 Sep 01; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L, Zambello R, Agostini C, Ambrosetti A, Chisesi T, Raimondi R, Bulian P, Pizzolo G, Semenzato G.
    Blood; 1990 Apr 01; 75(7):1525-30. PubMed ID: 2317560
    [Abstract] [Full Text] [Related]

  • 18. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD, Cawley JC.
    Leukemia; 1988 Jun 01; 2(6):377-81. PubMed ID: 3374170
    [Abstract] [Full Text] [Related]

  • 19. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD.
    Blood; 1983 Jun 01; 61(6):1132-7. PubMed ID: 6220750
    [Abstract] [Full Text] [Related]

  • 20. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD, Schwabe M, Prischl F, Wagner L, Lion T, Micksche M, Köller U.
    Eur J Haematol; 1987 Nov 01; 39(5):418-25. PubMed ID: 3691760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.